Study of ISIS 703802 in Participants With Hypertriglyceridemia, Type 2 Diabetes Mellitus, and Nonalcoholic Fatty Liver Disease
Completed · Phase 2 · Has a placebo group
Conditions studied: NAFLD, Diabetes Mellitus, Type 2, Hypertriglyceridemia, Fatty Liver, Nonalcoholic
In brief
This is a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study to evaluate the safety, including tolerability, of ISIS 703802 and to assess the efficacy of different doses and dosing regimens of ISIS 703802 on glucose and lipid metabolism, and liver fat in participants with hypertriglyceridemia, Type 2 diabetes mellitus (T2DM), and nonalcoholic fatty liver disease (NAFLD).
Key facts
- Study ID
- NCT03371355
- Run by
- Akcea Therapeutics
- People needed
- 105
- Starts
- 2017-12-21
- Expected to finish
- 2020-02-24
- Last updated by the study team
- 2021-02-01
Who can join
Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Clinical Sites — Chandler, Arizona, United States
- Clinical Site — Fountain Hills, Arizona, United States
- Clinical Site — Glendale, Arizona, United States
- Clinical Site — Mesa, Arizona, United States
- Clinical Site — Mesa, Arizona, United States
- Clinical Site — Phoenix, Arizona, United States
- Clinical Site — Phoenix, Arizona, United States
- Clinical Site — Phoenix, Arizona, United States
- Clinical Site — Huntington Park, California, United States
- Clinical Site — Los Angeles, California, United States
- Clinical Site — Montclair, California, United States
- Clinical Site — Panorama City, California, United States
- Clinical Site — Poway, California, United States
- Clinical Site — Boca Raton, Florida, United States
- Clinical Site — Jensen Beach, Florida, United States
- Clinical Site — Jupiter, Florida, United States
- Clinical Site — Miami, Florida, United States
- Clinical Site — Port Saint Lucie, Florida, United States
- Clinical Site — Atlanta, Georgia, United States
- Clinical Site — Chicago, Illinois, United States
- Clinical Site — Indianapolis, Indiana, United States
- Clinical Site — Louisville, Kentucky, United States
- Clinical Site — Edina, Minnesota, United States
- Clinical Site — Bridgeton, New Jersey, United States
- Clinical Site — Princeton, New Jersey, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.